TheTruth999
8 years ago
I think you're not alone. That risk has been around for awhile now, though, and the hospital stocks have done ok, so perhaps RCM will, too, regarding that risk.
I've often wondered if there's a silver lining there, too, if customers and prospective customers need help w/ their rcm even more when conditions are tighter.
I suppose R1 could also target health care providers with a small mix of Medicare/Medicaid, to help reduce the government risk.
TheTruth999
8 years ago
RCM's looking great, from several perspectives:
---it has broken out, with the next major resistance over 50% higher from here
---it's still off the radar. Only covered, barely, by one or two small-firm analysts. Investors chat rooms are silent, as was the Company for the most part for awhile now, as they focused on cleaning house and turning this thing around. Feels like hardly anyone knows or cares that things seem to have dramatically changed for the better. I love getting in when that is going on, as eventually the world will find out and the move from off the radar to on can be huge.
---the recent analysts conference webcast went very well, IMO. The Company is looking to greatly expand their sales efforts going forward, now that the Ascension deal has moved forward nicely. Guidance assumes no such sales, so this stock could keep moving up big if they expand business with current customers and eventually land some big new accounts, which they admitted they expect will happen starting this year.
---longer-term, there's still plenty of bounce potential left. The stock once had a mkt cap of about $3bil, which it mostly achieved during an impressively short 5 month burst in late 2010 and early 2011. Not at all saying that history will repeat, but if it does, with 250mil fully diluted shrs O/S now, that's about a 4 bagger from where the stk was just a couple weeks ago.
So, of course I bought shares and have kept adding!